Expression of HIV-1 Vpu Leads to Loss of the Viral Restriction Factor CD317/Tetherin from Lipid Rafts and Its Enhanced Lysosomal Degradation

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rollason, Ruth ^a   Dunstan, Katie ^a   Billcliff, Peter G ^a   Bishop, Paul ^a   Gleeson, Paul ^b   Wise, Helen ^c   Digard, Paul ^c   Banting, George ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD317 ANTIGEN; MEMBRANE PROTEIN; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN;

ARTICLE; BIOTINYLATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGRADATION; ENDOSOME; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LIPID RAFT; LYSOSOME; NONHUMAN; PLASMID; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; VIRUS PARTICLE;

ANTIGENS, CD; CELL MEMBRANE; GPI-LINKED PROTEINS; HIV INFECTIONS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LYSOSOMES; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; PROTEIN TRANSPORT; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRION;

EID: 84884552344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075680     Document Type: Article

References (51)

1. Goto T, Kennel SJ, Abe M, Takishita M, Kosaka M, et al. (1994) A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 84: 1922-1930. PubMed: 8080996.
2. Vidal-Laliena M, Romero X, March S, Requena V, Petriz J, et al. (2005) Characterization of antibodies submitted to the B cell section of the 8th Human Leukocyte Differentiation Antigens Workshop by flow cytometry and immunohistochemistry. Cell Immunol 236: 6-16. doi:10.1016/j.cellimm.2005.08.002. PubMed: 16157322.
3. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, et al. (2006) Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177: 3260-3265. PubMed: 16920966.
4. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430. doi:10.1038/nature06553. PubMed: 18200009.
5. Van Damme N, Goff G, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein. Cell Host Microbe 3: 245-252. doi:10.1016/j.chom.2008.03.001. PubMed: 18342597.
6. Dubé M, Bego MG, Paquay C, Cohen EA, (2010) Modulation of HIV-1-host interaction: role of the Vpu accessory protein. Retrovirology 7: 114-133. doi:10.1186/1742-4690-7-S1-P114. PubMed: 21176220.
7. Billcliff PG, Rollason R, Prior I, Owen DM, Gaus K, et al. (2013) CD317/Tetherin is an Organiser of Membrane Microdomains. J Cell Sci 126: 1553-1564. doi:10.1242/jcs.112953. PubMed: 23378022.
8. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, et al. (2003) BST-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4: 694-709. doi:10.1034/j.1600-0854.2003.00129.x. PubMed: 12956872.
9. Elortza F, Mohammed S, Bunkenborg J, Foster LJ, Nühse TS, et al. (2006) Modification-specific proteomics of plasma membrane proteins: identification and characterization of glycosylphosphatidylinositol-anchored proteins released upon phospholipase D treatment. J Proteome Res 5: 935-943. doi:10.1021/pr050419u. PubMed: 16602701.
10. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, et al. (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139: 499-511. doi:10.1016/j.cell.2009.08.039. PubMed: 19879838.
11. Andrew AJ, Kao S, Strebel K, (2011) The C-terminal hydrophobic region in human BST/2tetherin functions as a second transmembrane domain motif. J Biol Chem 286: 39967-39981. doi:10.1074/jbc.M111.287011. PubMed: 21937450.
12. Lingwood D, Simons K, (2010) Lipid Rafts As as Membrane-Organizing Principle. Science 327: 46-50. doi:10.1126/science.1174621. PubMed: 20044567.
13. Kusumi A, Suzuki KGN, Kasai RS, Ritchie K, Fujiwara TK, (2011) Hierarchical mesoscale domain organization of the plasma membrane. Trends Biochem Sci 36: 604-615. doi:10.1016/j.tibs.2011.08.001. PubMed: 21917465.
14. Rollason R, Korolchuk V, Hamilton C, Schu P, Banting G, (2007) Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120: 3850-3858. doi:10.1242/jcs.003343. PubMed: 17940069.
15. Hinz A, Miguet N, Natrajan G, Usami Y, Yamanaka H, et al. (2010) Structural Basis of HIV-1 Tethering to Membranes by the BST-2/Tetherin Ectodomain. Cell Host Microbe 22: 314-323. PubMed: 20399176.
16. Swiecki M, Scheaffer SM, Allaire M, Fremont DH, Colonna M, et al. (2011) Structural and biophysical analysis of BST-2/tetherin ectodomains reveals an evolutionary conserved design to inhibit virus release. J Biol Chem 286: 2987-2997. doi:10.1074/jbc.M110.190538. PubMed: 21084286.
17. Yang H, Wang J, Jia X, McNatt MW, Zang T, et al. (2010) Structural insight into the mechanisms of enveloped virus tethering by tetherin. Proc Natl Acad Sci U S A 107: 18428-18432. doi:10.1073/pnas.1011485107. PubMed: 20940320.
18. Schubert HL, Zhai Q, Sandrin V, Eckert DM, Garcia-Maya M, et al. (2010) Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations. Proc Natl Acad Sci U S A 107: 17951-17966. doi:10.1073/pnas.1008206107. PubMed: 20880831.
19. Lopez LA, Yang SJ, Hauser H, Exline CM, Haworth KG, et al. (2010) Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal. J Virol 84: 7243-7255. doi:10.1128/JVI.02636-09. PubMed: 20444895.
20. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P, (2009) Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A 106: 2886-2891. doi:10.1073/pnas.0811014106. PubMed: 19179289.
21. Mansouri M, Viswanathan K, Douglas JL, Hines J, Gustin J, et al. (2009) Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus. J Virol 83: 9672-9681. doi:10.1128/JVI.00597-09. PubMed: 19605472.
22. Altmann SM, Grünberg RG, Lenne PF, Ylänne J, Raae A, et al. (2002) Pathways and intermediates in forced unfolding of spectrin repeats. Structure 10: 1085-1096. doi:10.1016/S0969-2126(02)00808-0. PubMed: 12176386.
23. Lee CK, Wang YM, Huang LS, Lin S, (2007) Atomic force microscopy: determination of unbinding force, off rate and energy barrier for protein Äìligand interaction. Micron 38: 446-461.
24. Tokarev A, Guatelli JC, (2011) Misdirection of membrane trafficking by HIV-1 Vpu and Nef. Cellular Logistics 1: 90-102. doi:10.4161/cl.1.3.16708. PubMed: 21922073.
25. Florin EL, Moy VT, Gaub HE, (1994) Adhesion forces between individual ligand-receptor pairs. Science 264: 415-417. doi:10.1126/science.8153628. PubMed: 8153628.
26. Hussain A, Das SR, Tanwar C, Jameel S, (2007) Oligomerization of the human immunodeficiency viris type 1 (HIV-1) Vpu protein- a genetic, biochemical and biophysical analysis. Virol J 4: 81-92. doi:10.1186/1743-422X-4-81. PubMed: 17727710.
27. Lopez CF, Montal M, Blasie JK, Klein ML, Moore PB, (2002) Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1. Biophys J 83: 1259-1267. doi:10.1016/S0006-3495(02)73898-8. PubMed: 12202353.
28. Andrew A, Strebel K, (2010) HIV-1 Vpu targets cell surface markers CD4 and BST-2 through disticnt mechanisms. Mol Aspects Med 31: 407-417. doi:10.1016/j.mam.2010.08.002. PubMed: 20858517.
29. Pralle A, Prummer M, Florin EL, Stelzer EH, Hoerber J, (1999) Three-dimensional high-resolution particle tracking for optical tweezers by forward scattered light. Microsc Res Tech 44: 378-386. doi:10.1002/(SICI)1097-0029(19990301)44:5. PubMed: 10090214.
30. Kobayashi T, Ode H, Yoshida T, Sato K, Gee P, et al. (2011) Identification of Amino Acids in the Human Tetherin Transmembrane Domain Responsible for HIV-1 Vpu Interaction and Susceptibility. J Virol 85: 932-945. doi:10.1128/JVI.01668-10. PubMed: 21068238.
31. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, et al. (2009) Species-specific activity of HIV-1 Vpu and positive selcetion of tetherin transmembrane domain variants. PLOS Pathog 5: e1000300.
32. Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, et al. (2009) The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J Virol 83: 7536-7546. doi:10.1128/JVI.00620-09. PubMed: 19474106.
33. Tischer C, Altmann S, Fisinger S, Heinrich Hörber JK, Stelzer EHK, et al. (2001) Three-dimensional thermal noise imaging. Appl Phys Lett 79: 3878. doi:10.1063/1.1423404.
34. Florin EL, Pralle A, Stelzer E, Hoerber J, (1998) Photonic force microscope calibration by thermal noise analysis. Applied Physics A: Materials Science & Processing 66: 75-78. doi:10.1007/s003390051103.
35. Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Früh K, et al. (2009) Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 83: 7931-7947. doi:10.1128/JVI.00242-09. PubMed: 19515779.
36. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, et al. (2009) Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLOS Pathog 5: e1000450. PubMed: 19478868.
37. Pardieu C, Vigan R, Wilson SJ, Calvi A, Zang T, et al. (2010) The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. PLOS Pathog 15: e1000843. PubMed: 20419159.
38. Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, et al. (2009) HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLOS Pathog 5: e1000574. PubMed: 19730691.
39. Miyagi E, Andrew AJ, Kao S, Strebel K, (2009) Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A 106: 2828-2873. PubMed: 19196977.
40. Dube M, Roy BB, Guiot-Guillain P, Binette J, Mercier J, et al. (2010) Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLOS Pathog 6: e1000856.
41. Hauser H, Lopez LA, Yang SJ, Oldenburg JE, Exline CM, et al. (2010) HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 7: 51-67. doi:10.1186/1742-4690-7-51. PubMed: 20529266.
42. Dubé M, Paquay C, Roy BB, Bego MG, Mercier J, et al. (2011) HIV-1 Vpu Antagonizes BST-2 by Interfering Mainly with the Trafficking of Newly Synthesized BST-2 to the Cell Surface. Traffic 12: 1714-1729. doi:10.1111/j.1600-0854.2011.01277.x. PubMed: 21902775.
43. Ruiz A, Hill MS, Schmitt K, Stephens EB, (2010) Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release. Virology 408: 89-102. doi:10.1016/j.virol.2010.08.031. PubMed: 20880565.
44. López Bernal A, (2007) The regulation of uterine relaxation. Semin Cell Dev Biol 18: 340-347. doi:10.1016/j.semcdb.2007.05.002. PubMed: 17582797.
45. Hammonds J, Spearman P, (2010) An Imperfect Rule for the Particle Roost. Cell Host Microbe 7: 261-263. doi:10.1016/j.chom.2010.04.001. PubMed: 20413094.
46. López Bernal A, (2007) Prostaglandins, oxytocin, and antagonists. In: Petraglia F, Strauss JF, Gabbe SG, Weiss G, eds. Preterm Birth Mechanisms, mediators, prediction, prevention and interventions. Oxford: Informa UK Ltd. pp. pp. 167-180.
47. Masuyama N, Kuronita T, Tanaka R, Muto T, Hirota Y, et al. (2009) HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin. J Biol Chem 284: 15927-15941. doi:10.1074/jbc.M109.005124. PubMed: 19359243.
48. Cao W, Bover L, Cho M, Wen X, Hanabuchi S, et al. (2009) Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med 206: 1603-1614. doi:10.1084/jem.20090547. PubMed: 19564354.
49. Oakley FD, Smith RL, Engelhardt JF, (2009) Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem 284: 33255-33264. doi:10.1074/jbc.M109.042127. PubMed: 19801678.
50. Ashkin A, Dziedzic JM, Bjorkholm JE, Chu S, (1986) Observation of a single-beam gradient force optical trap for dielectric particles. Opt Lett 11: 288-290. doi:10.1364/OL.11.000288. PubMed: 19730608.
51. Andrew AJ, Miyagi E, Kao S, Strebel K, (2009) The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology 6: 80-96. doi:10.1186/1742-4690-6-S3-P80. PubMed: 19737401.